Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 3Dermatologic 2Plasma cell 1

Conditions

Multiple Myeloma 7Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 63fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 52Mycophenolic Acid 42Cyclosporine 35Whole-Body Irradiation 34Tacrolimus 32Busulfan 30Antilymphocyte Serum 30Filgrastim 28Radiotherapy 25Methotrexate 23Methylprednisolone 17Melphalan 17Etoposide 15Cord Blood Stem Cell Transplantation 14Therapeutics 10Flow Cytometry 10fludarabine 9Sirolimus 8Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8Polymerase Chain Reaction 7sargramostim 6Rituximab 6Alemtuzumab 6Thiotepa 5Prednisone 5Carmustine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × romidepsin × Plasma cell × Clear all
NCT01947140 2022-11-23

PDX+Romi

Columbia University

Phase 1/2 Completed
57 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡